Disease Susceptibility to ST11 Complex Meningococci Bearing Serogroup C or W135 Polysaccharide Capsules, North America1
Andrew J. Pollard(University of Oxford), Simon Dobson(Baylor College of Medicine), J Ochnio(University of British Columbia), Martin Callaghan(University of Oxford), Margaret Kay Ho(University of British Columbia), Mark Bigham(Canadian Blood Services)
Cited by 34
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661